Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

PLoS Computational Biology is a premier open-access journal published by the Public Library of Science, committed to advancing the understanding of complex biological data through computational approaches. Since its inception in 2005, the journal has made significant strides in the fields of Cellular and Molecular Neuroscience, Computational Theory and Mathematics, Ecology, Genetics, and Molecular Biology, achieving a notable Q1 ranking in various categories as of 2023. With an exceptional impact factor and an esteemed ranking—such as Rank #23/176 in Computational Theory and Mathematics—PLoS Computational Biology provides a vital platform for researchers, professionals, and students to disseminate their cutting-edge findings and insights. The journal's open-access model ensures that high-quality research is freely accessible worldwide, fostering collaboration and innovation across disciplines. Located in San Francisco, CA, it serves as a hub for the global scientific community, making it an indispensable resource for anyone at the forefront of computational biology and its diverse applications.

IEEE-ACM Transactions on Computational Biology and Bioinformatics is a prestigious journal published by the IEEE Computer Society, focusing on the interdisciplinary field of computational biology and bioinformatics. Established in 2004, this journal has made significant strides in contributing to our understanding of complex biological systems through quantitative methods and computational techniques, and it spans a converged publication period through 2024. As a notable resource with an impact factor that positions it in the second quartile in the domains of Applied Mathematics, Biotechnology, and Genetics, it serves as an essential platform for researchers and professionals seeking to disseminate their findings to a global audience. The journal ranks impressively in Scopus, with Applied Mathematics holding a rank of #38 out of 635 (94th percentile) and Genetics at #86 out of 347 (75th percentile), highlighting its significant influence in the scientific community. While the journal is not open-access, it provides valuable insights and cutting-edge research that are crucial for advancing the fields of bioinformatics and computational biology, making it indispensable for students, researchers, and practitioners alike.

Current Bioinformatics, an esteemed journal published by Bentham Science Publishers Ltd, serves as a pivotal platform for the dissemination of cutting-edge research in the fields of bioinformatics, biochemistry, computational mathematics, genetics, and molecular biology. With an ISSN of 1574-8936 and an E-ISSN of 2212-392X, this journal has established itself as a vital resource for researchers, professionals, and students keen on exploring interdisciplinary approaches to biological data analysis. Its prominence is reflected in its quartile rankings for 2023, where it stands in Q3 for biochemistry and computational mathematics, alongside Q4 rankings in genetics and molecular biology. Current Bioinformatics, located in the United Arab Emirates and converging from 2007 to 2024, aims to foster innovation in the field by presenting original research articles, reviews, and case studies that drive forward our understanding of complex biological systems through computational techniques. This journal is an integral resource for those wishing to stay at the forefront of bioinformatics research and applications.

BRIEFINGS IN BIOINFORMATICS is a premier academic journal dedicated to the dynamic field of bioinformatics, published by Oxford University Press. With a prestigious standing reflected in its Q1 quartile rankings in both Information Systems and Molecular Biology, this journal serves as an essential resource for researchers, professionals, and students eager to explore the intersection of biology and computational sciences. The journal not only publishes high-impact research articles but also reviews and critical commentaries that push the boundaries of understanding in bioinformatics. As it converges its objectives towards fostering innovation and knowledge dissemination from 2000 to 2024, BRIEFINGS IN BIOINFORMATICS offers rich insights that remain pivotal to advancements in genomic studies, data integration, and computational tools. Its ranking in the top percentiles of Scopus—30th among 394 in Computer Science and 44th among 410 in Molecular Biology—underscores the journal's influential presence in the academic community. Engaging with the latest research and trends, this journal is integral for anyone invested in the future of life sciences and data analytics.

BioData Mining is a distinguished open access journal published by BMC, focusing on the dynamic intersection of bioinformatics, computational mathematics, and molecular biology. Since its inception in 2008, this journal has provided a critical platform for researchers and professionals to publish their findings, contributing significantly to the collective knowledge in fields such as biochemistry, computational theory, and genetics. With a robust impact factor and a commendable h-index, BioData Mining continues to be a vital resource for academic and industrial advancements, ranked in the top quartiles in various categories according to the 2023 metrics. The journal's commitment to open access ensures that cutting-edge research is readily available to the global scientific community, thereby enhancing visibility and fostering collaboration among scholars. Whether you are a researcher, student, or practitioner, engaging with BioData Mining will equip you with relevant insights and developments in the fast-evolving realm of bioinformatics.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

BIOINFORMATICS, published by Oxford University Press, is a leading journal in the realms of biochemistry, computational mathematics, and computer science, with a notable impact factor that underscores its significance in the field. Since its inception in 1985 and continuing through its expected convergence in 2024, the journal has maintained a prestigious reputation, proudly residing in the Q1 category across multiple disciplines, including molecular biology and statistics. With a Scopus ranking placing it within the top percentiles of its categories, BIOINFORMATICS serves as an essential platform for disseminating high-quality research that advances knowledge and innovation at the intersection of biology and computational sciences. This journal not only offers both subscription and open access options, ensuring wider availability of its cutting-edge research, but it has also become a crucial resource for researchers, professionals, and students aiming to stay at the forefront of bioinformatics and related fields. Explore the latest findings and trends that define the future of biological research through this esteemed publication, any inquiries regarding the journal can be directed to its offices located at Great Clarendon St, Oxford OX2 6DP, England.

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.